What is the ROE (Return on Equity) of Masimo this year?
The ROE of Masimo this year is 0.06 undefined.
Masimo ROE 2024
Masimo ROE
0.06
Ticker
MASI
ISIN
US5747951003
WKN
578074
In 2024, Masimo's return on equity (ROE) was 0.06, a -44.28% increase from the 0.11 ROE in the previous year.
Masimo Aktienanalyse
What does Masimo do?
Masimo Corporation is an American medical technology company based in Irvine, California. The company was founded in 1989 by Professor Joe Kiani, who is still the chairman and CEO of the company today. With innovative products and advanced technology, Masimo aims to optimize medical diagnostic and treatment procedures to improve patient care. The business model of Masimo Corp focuses on developing and marketing products and solutions for patient monitoring and treatment in hospitals, intensive care facilities, and outpatient clinics. The company relies on high levels of innovation and collaboration with physicians, scientists, and other experts. The goal is to improve existing medical procedures, explore new applications for the technology, and optimize patient care. Masimo Corp's products are divided into different divisions that focus on various aspects of medical care. One example is the "Patient Monitoring" division, which offers various monitoring systems for vital signs such as respiration, pulse, and oxygen saturation. This includes products like the Rad-67 pulse oximeter or the Root patient monitor, which continuously monitor patients during treatment to enhance safety and effectiveness. Another division is "Anesthesia and Sedation," which focuses on solutions for anesthesiologists and intensive care specialists. Masimo Corp offers products such as the SedLine brain monitor or the EMMA main gas monitor, which enable physicians to control anesthesia depth more precisely and reduce the risk of complications. In addition to patient monitoring systems, Masimo Corp also provides solutions for neonatal care. The "Neonatal Care" division includes products like the Masimo Radical-7 pulse oximeter for monitoring premature infants or the Pronto-7 pulse oximeter for fast and accurate monitoring of newborns in the delivery room. Furthermore, Masimo Corp has developed products for monitoring surgical patients. The "Surgical and Minimally Invasive Monitoring" division, for example, offers the MOC-9 monitoring system for precise monitoring of hemodynamics during surgery. A unique product of Masimo Corp is also the Masimo SET sensor, which provides more accurate and reliable measurement of blood oxygen saturation than traditional pulse oximeter sensors. The company has filed over 100 patents worldwide for this technology and has been recognized with numerous awards and accolades. In summary, Masimo Corp is an innovative company specializing in improving medical care through the development and marketing of products for patient monitoring and treatment. With its state-of-the-art technologies and collaboration with experts in medical research, Masimo Corp sets standards for patient safety and treatment effectiveness. Masimo ist eines der beliebtesten Unternehmen auf Eulerpool.com.ROE Details
Decoding Masimo's Return on Equity (ROE)
Masimo's Return on Equity (ROE) is a fundamental metric evaluating the company's profitability relative to its equity. Calculated by dividing net income by shareholder's equity, ROE illustrates how effectively the company is generating profits from shareholders’ investments. A higher ROE represents enhanced efficiency and profitability.
Year-to-Year Comparison
Analyzing Masimo's ROE on a yearly basis aids in tracking its profitability trends and financial performance. An increasing ROE suggests enhanced profitability and value generation for shareholders, whereas a declining ROE may indicate issues in profit generation or equity management.
Impact on Investments
Masimo's ROE is instrumental for investors assessing the company's profitability, efficiency, and investment attractiveness. A robust ROE indicates the firm’s adeptness at converting equity investments into profits, thereby enhancing its appeal to potential and current investors.
Interpreting ROE Fluctuations
Changes in Masimo’s ROE can emanate from variations in net income, equity capital, or both. These fluctuations are scrutinized to evaluate management’s effectiveness, financial strategies, and the inherent risks and opportunities, aiding investors in making informed decisions.
Frequently Asked Questions about Masimo stock
How has the Return on Equity (ROE) of Masimo developed compared to the previous year?
The ROE of Masimo has increased by -44.28% decreased compared to the previous year.
What impact does a high ROE (Return on Equity) have on investors of Masimo?
A high ROE indicates that Masimo generates good returns on capital and is successful in monetizing its investments. This is a positive indicator for investors.
What impact does a low ROE (Return on Equity) have on investors of Masimo?
A low ROE can indicate that Masimo is having difficulties monetizing its investments successfully and can be a negative signal for investors.
How does a change in the ROE (Return on Equity) of Masimo affect the company?
A change in ROE (Return on Equity) of Masimo can be an indicator of the financial performance of the company and demonstrate how successful the company is compared to other companies in the same industry.
How to calculate the ROE (Return on Equity) of Masimo?
The ROE (Return on Equity) is calculated by dividing the company's profit by the total equity. The formula is: ROE = Profit / Total equity.
Which factors influence the ROE (Return on Equity) of Masimo?
Some factors that can influence Masimo's Return on Equity (ROE) include the efficiency in using equity, the profitability of the company, and the financing structure.
What strategic measures can take to improve the ROE (Return on Equity)?
To improve the Return on Equity (ROE), can take measures such as cost savings, increasing revenue, improving efficiency in the use of equity, and making changes in the financing structure. It is important for the company to conduct a thorough review of its financial situation to determine the best strategic actions to improve ROE.
How much dividend does Masimo pay?
Over the past 12 months, Masimo paid a dividend of 1 USD . This corresponds to a dividend yield of about 0.58 %. For the coming 12 months, Masimo is expected to pay a dividend of 6.54 USD.
What is the dividend yield of Masimo?
The current dividend yield of Masimo is 0.58 %.
When does Masimo pay dividends?
Masimo pays a quarterly dividend. This is distributed in the months of .
How secure is the dividend of Masimo?
Masimo paid dividends every year for the past 0 years.
What is the dividend of Masimo?
For the upcoming 12 months, dividends amounting to 6.54 USD are expected. This corresponds to a dividend yield of 3.79 %.
In which sector is Masimo located?
Masimo is assigned to the 'Health' sector.
Wann musste ich die Aktien von Masimo kaufen, um die vorherige Dividende zu erhalten?
To receive the latest dividend of Masimo from 12/11/2012 amounting to 1 USD, you needed to have the stock in your portfolio before the ex-date on 11/23/2012.
When did Masimo pay the last dividend?
The last dividend was paid out on 12/11/2012.
What was the dividend of Masimo in the year 2023?
In the year 2023, Masimo distributed 0 USD as dividends.
In which currency does Masimo pay out the dividend?
The dividends of Masimo are distributed in USD.
Stock savings plans offer an attractive way for investors to build wealth over the long term. One of the main advantages is the so-called cost-average effect: by regularly investing a fixed amount in stocks or stock funds, you automatically buy more shares when prices are low, and fewer when they are high. This can lead to a more favorable average price per share over time. In addition, stock savings plans allow small investors access to expensive stocks, as they can participate with small amounts. Regular investment also promotes a disciplined investment strategy and helps to avoid emotional decisions, such as impulsive buying or selling. Furthermore, investors benefit from the potential appreciation of the stocks as well as from dividend distributions, which can be reinvested, enhancing the compounding effect and thus the growth of the invested capital.
The Masimo stock can be added to a savings plan with the following providers: Trade Republic
Andere Kennzahlen von Masimo
Our stock analysis for Masimo Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Masimo Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.
